Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Director departure
|
|
Cara Therapeutics, Inc. (CARA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/04/2023 |
4
| Posner Christopher (President and CEO) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 4,307 shares
@ $3.07, valued at
$13.2k
|
|
| 08/04/2023 |
4
| Boudreau Helen M (Director) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 155,747 options to buy
@ $3.09, valued at
$481.3k
|
|
| 05/09/2023 |
4
| Posner Christopher (President and CEO) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 3,869 shares
@ $4.4, valued at
$17k
|
|
| 03/07/2023 |
4
| Posner Christopher (President and CEO) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 5,987 shares
@ $9.71, valued at
$58.1k
|
|
| 03/07/2023 |
4
| Menzaghi Frederique Ph.D. (Chief Scientific Off,SVP-R&D) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 6,802 shares
@ $9.71, valued at
$66k
|
|
| 03/07/2023 |
4
| Terrillion Scott (Sec'y; Chief Compliance & G.C.) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 6,256 shares
@ $9.71, valued at
$60.7k
|
|
| 03/07/2023 |
4
| Goncalves Joana (Chief Medical Officer) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 6,221 shares
@ $9.71, valued at
$60.4k
|
|
| 02/03/2023 |
4
| Posner Christopher (President and CEO) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 4,191 shares
@ $11.8, valued at
$49.5k
|
|
| 01/19/2023 |
4
| von Moltke Lisa (Director) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 45,841 options to buy
@ $10.74, valued at
$492.3k
|
|
| 01/19/2023 |
4
| Goncalves Joana (Chief Medical Officer) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 2,265 shares
@ $10.81, valued at
$24.5k
|
|
| 01/03/2023 |
4
| Goncalves Joana (Chief Medical Officer) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 2,265 shares
@ $10.18, valued at
$23.1k
|
|
| 12/23/2022 |
4
| Menzaghi Frederique Ph.D. (Chief Scientific Off,SVP-R&D) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 3,506 shares
@ $11.27, valued at
$39.5k
|
|
| 12/23/2022 |
4
| Goncalves Joana (Chief Medical Officer) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 2,992 shares
@ $11.27, valued at
$33.7k
|
|
| 12/23/2022 |
4
| Terrillion Scott (Sec'y; Chief Compliance & G.C.) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 2,561 shares
@ $11.27, valued at
$28.9k
|
|
| 11/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2022 |
4
| VOGELBAUM MARTIN (Director) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 10,800 shares
@ $10.28, valued at
$111k
|
|
| 09/14/2022 |
4
| Maynard Ryan D (CFO) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 225,000 options to buy
@ $10.75, valued at
$2.4M
|
|
| 07/19/2022 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 3,600 shares
@ $9.05, valued at
$32.6k
|
|
| 07/19/2022 |
4
| BAINS HARRISON M JR (Director) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 7,200 shares
@ $9.05, valued at
$65.2k
|
|
| 06/16/2022 |
4
| Makara Richard (VP, Head of Accting;Controller) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 7,500 shares
@ $0 |
|
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Ives Jeffrey L. (Director) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 11,876 shares
@ $0
Granted 16,996 options to buy
@ $8.42, valued at
$143.1k
|
|
| 06/06/2022 |
4
| BAINS HARRISON M JR (Director) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 11,876 shares
@ $0
Granted 16,996 options to buy
@ $8.42, valued at
$143.1k
|
|
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Terrillion Scott (Sec'y; Chief Compliance & G.C.) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 1,642 shares
@ $11.91, valued at
$19.6k
|
|
| 04/05/2022 |
4
| Goncalves Joana (Chief Medical Officer) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 1,642 shares
@ $11.91, valued at
$19.6k
|
|
| 04/05/2022 |
4
| Menzaghi Frederique Ph.D. (Chief Scientific Off,SVP-R&D) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 1,784 shares
@ $11.91, valued at
$21.2k
|
|
| 04/05/2022 |
4
| Posner Christopher (President and CEO) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 2,006 shares
@ $12.67, valued at
$25.4k
|
|
| 03/04/2022 |
4
| Reilly Thomas Charles (CFO) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 2,044 shares
@ $11.38, valued at
$23.3k
|
|
| 03/04/2022 |
4
| Terrillion Scott (Sec'y; Chief Compliance & G.C.) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Sold 1,787 shares
@ $11.38, valued at
$20.3k
|
|
| 03/01/2022 |
4
| Terrillion Scott (Sec'y; Chief Compliance & G.C.) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Sold 1,972 shares
@ $10.29, valued at
$20.3k
Granted 5,333 shares
@ $0
Granted 40,000 options to buy
@ $10.46, valued at
$418.4k
|
|
| 03/01/2022 |
4
| Reilly Thomas Charles (CFO) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 5,333 shares
@ $10.29, valued at
$54.9k
Granted 40,000 options to buy
@ $10.46, valued at
$418.4k
|
|
| 03/01/2022 |
4
| Posner Christopher (President and CEO) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 39,000 shares
@ $0
Granted 121,000 options to buy
@ $10.46, valued at
$1.3M
|
|
| 03/01/2022 |
4
| Menzaghi Frederique Ph.D. (Chief Scientific Off,SVP-R&D) has filed a Form 4 on Cara Therapeutics, Inc.|
Txns:
| Granted 20,000 shares
@ $0
Sold 2,114 shares
@ $10.29, valued at
$21.8k
Granted 40,000 options to buy
@ $10.46, valued at
$418.4k
|
|
|
|
|